- Report
- October 2024
- 184 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- November 2021
- 256 Pages
Global
From €2495EUR$2,625USD£2,096GBP
€4991EUR$5,250USD£4,193GBP
- Report
- November 2022
- 65 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- October 2023
- 172 Pages
Global
From €4278EUR$4,500USD£3,594GBP
The Next Generation Biomanufacturing market is a subset of the biotechnology industry that focuses on the development of advanced manufacturing technologies for the production of biopharmaceuticals. This includes the use of cell and gene therapies, as well as the development of novel bioprocessing techniques. These technologies are used to improve the efficiency and cost-effectiveness of biopharmaceutical production, while also reducing the environmental impact of the process.
The Next Generation Biomanufacturing market is driven by the increasing demand for biopharmaceuticals, as well as the need to reduce the cost of production. This has led to the development of new technologies such as single-use bioreactors, automated bioprocessing systems, and advanced analytics. These technologies are being used to improve the efficiency and cost-effectiveness of biopharmaceutical production, while also reducing the environmental impact of the process.
Some of the companies in the Next Generation Biomanufacturing market include Thermo Fisher Scientific, Merck KGaA, GE Healthcare, Lonza, and Sartorius AG. Show Less Read more
